Jeffrey Bacha Insider Profile

4 Followers
Jeffrey Bacha, Director at Kintara Therapeutics, holds 64.05K shares in Kintara Therapeutics (Ticker: KTRA).
tipranks
Jeffrey Bacha

Jeffrey Bacha
Kintara Therapeutics (KTRA)
Director

Ranked #2,782 out of 78,624 Corporate Insiders

Profitable Transactions

44%
7 out of 16 Profitable Transactions

Average Return

+30.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$89K
100.00%
A breakdown of Jeffrey Bacha's holdings

Insider Roles

Kintara Therapeutics
(KTRA)
Director
Roles that Jeffrey Bacha holds in companies

Most Profitable Insider Trade

Stock:
Kintara Therapeutics
(KTRA)
Rating:Informative Buy
Date:Jul 16, 2015 - Jul 16, 2016
Return:+270.30%
The most profitable trade made by Jeffrey Bacha

Jeffrey Bacha's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Kintara Therapeutics
Apr 03, 2018
Director
Uninformative Buy
563.20
$89.03K
Success Rate for
KTRA
7 out of 16 profitable transactions on
KTRA
44%
Average Return for
KTRA
Average return per transaction on
KTRA
+30.84%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 21, 2014
Informative Buy
$5.00K
-
$1.00
-27.00%
Feb 13, 2014
Informative Buy
$4.00K
-
$0.80
-21.30%
Mar 20, 2014
Informative Buy
$13.00K
-
$1.30
-32.50%
Sep 19, 2014
Informative Buy
$3.92K
-
$0.98
-16.60%
Sep 16, 2014
Informative Buy
$3.74K
-
$0.75
-9.70%
List of latest transactions for each holding click on a transaction to see Jeffrey Bacha's performance on stock

Jeffrey Bacha insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Bacha?
The percentage of profitable transactions made by Jeffrey Bacha is 44%.
    What is the average return per transaction made by Jeffrey Bacha?
    The average return per transaction made by Jeffrey Bacha is 30.80%.
      What stocks does Jeffrey Bacha hold?
      Jeffrey Bacha holds: KTRA stocks.
        What was Jeffrey Bacha’s latest transaction?
        Jeffrey Bacha latest transaction was an Uninformative Buy of $563.20.
          What was Jeffrey Bacha's most profitable transaction?
          Jeffrey Bacha’s most profitable transaction was an Informative Buy of KTRA stock on July 16, 2015. The return on the trade was 270.30%.
            What is Jeffrey Bacha's role in Kintara Therapeutics?
            Jeffrey Bacha's role in Kintara Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.